Navigation Links
New OxyContin® Has Lower Street Price Than Old Crushable Formulation
Date:11/15/2011

JACKSONVILLE, Fla., Nov. 15, 2011 /PRNewswire/ -- The new harder to crush version of OxyContin® has a lower street price than the original, according to research revealed at a conference of law enforcement officers today. Last week, the Centers for Disease Control and Prevention (CDC) announced that every day 100 people die from drug overdoses in the United States, 74% involving prescription opioid pain relievers. A new formulation of the opioid pain reliever OxyContin was launched in 2010, accompanied by hope that it would deter drug abuse, injection and overdose. A year later, researchers have shown that the new formulation sells for 28% less than the original OxyContin on the black market, using street price data from the RADARS® System StreetRx.com, an online crowdsourcing website recently featured in Fortune magazine. The price per milligram of the new difficult to crush OxyContin is $0.56, compared to $0.78 for the original during the first half of this year. Similar results were seen in a survey of law enforcement officers from the RADARS System Drug Diversion program.

The results were presented by Nabarun Dasgupta at the 22nd Annual Educational Training Conference of the National Association of Drug Diversion Investigators (NADDI), in Jacksonville, Florida. Establsihed in 1989, NADDI is a unique organization whose hundreds of members are responsible for investigating and prosecuting pharmaceutical drug diversion throughout the United States. The audience, made up mostly of law enforcement officials, reacted positively to the street price data on OxyContin and confirmed that the new formulation was not worth as much as the original. "As the pharmaceutical industry tries to engineer new drugs that are harder to crush, snort or inject, the unregulated free market of diverted prescription drugs can reveal how effective these efforts are," says Dasgupta. "In the end, these products will be judged by the human suffering they cause or prevent. Black market street prices can tell us that story ahead of time."

The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System (www.radars.org) is a surveillance system run by Denver Health for measuring rates of abuse, misuse and diversion throughout the United States, contributing to the understanding of trends and aiding the development of effective interventions. StreetRx.com and Drug Diversion Program are components of the RADARS System. The Drug Diversion Program is composed of hundreds of prescription drug diversion investigators or regulatory agencies who are surveyed quarterly and asked to report street prices for prescription drugs. The study is conducted by Dr. Hilary Surratt of Nova Southeastern University, Fort Lauderdale, Florida. StreetRx.com is a website that assembles and organizes online crowd sourced information about the black-market price of prescription drugs. The street market for prescription medications—such as Vicodin®, Adderall®, and fentanyl—comprises a vast underground economy that is little studied and poorly understood. Launched by public-health researchers at Epidemico, Boston, Massachusetts, StreetRx closes this knowledge gap, providing an extensive, searchable database of the latest street price data.

In the analysis, data collected during the first six months of 2011 from StreetRx.com and Drug Diversion were compared. The small difference between the price estimates was expected, as individual drug users have a stronger self-interest to bargain for lower prices than undercover law enforcement agents who are trying to make a buy.

Twitter: @StreetRx
Web: www.streetrx.com


'/>"/>
SOURCE StreetRx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Confirms OxyContin® Patent Challenge
2. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
3. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
4. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
5. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
8. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
9. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
10. Kmart Lowers Flu Shot Price to $10
11. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... and SEOUL, South Korea ... Biosys­tems Menarini and Macrogen, Inc. today announced they ... and innovative procedures for precision medicine in cancer. ... Silicon Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput ... tests certified under the Clinical Laboratory Improvement Amendments ...
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a ... and medical practitioners, announced today the recent launching of ... visitors a variety of features that enhance the user ... surgery supplies. --> ... a fairly new company that started in early 2016, ...
(Date:2/12/2016)... 12, 2016 Indiso ... den ungedeckten medizinischen Bedarf bei Lungen- und ... klinischen Forschungsprogramms bekannt. Das Programm, das sich ... ihrer respiratorischen Funktionen und anderer klinischer Parameter. ... Medizintechnikunternehmen, das sich auf den ungedeckten medizinischen ...
Breaking Medicine Technology:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Faces and Voices of Recovery, the leading national organization representing the growing community ... candidates for public office to include Family Recovery in policies addressing addiction. ...
(Date:2/13/2016)... Tennessee (PRWEB) , ... February 13, 2016 , ... ... Herrington School of Nursing with an in-kind gift of a VeinViewer® Vision ... students as they learn how to start an IV and draw blood, combining ...
(Date:2/12/2016)... ... ... Mystic Buddha Publishing House presents Valentine’s Day tips on different forms and ... Dr. Frederick Lenz. , According to Publisher Roger Cantu, “Blue Skies Buddha ... and helping others. Valentine’s Day celebrates love in all its forms, and Blue ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... life cycle of pharmaceutical products, garnering increased attention from all stakeholders in the ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare Center for Healthcare ... Hospital on April 5-7. The series is a multi-day, multi-workshop event designed to ... cover a broad range of topics, including coaching skills, the scientific method of ...
Breaking Medicine News(10 mins):